Middle East and Africa Dialysis Equipment Market Outlook (2021-2031)

The dialysis equipment market in the Middle East and Africa is projected to grow significantly, reaching a size of USD 382.7 million by 2031, up from USD 346.9 million in 2024. This market is expected to record a compound annual growth rate (CAGR) of 1.4% from 2025 to 2031.

Executive Summary and Market Analysis

The increase in the dialysis equipment market in the Middle East and Africa is primarily driven by the rising prevalence of kidney diseases, particularly chronic kidney disease (CKD) and end-stage renal disease (ESRD). These conditions are often related to comorbidities such as diabetes and hypertension. The region has some of the highest diabetes rates globally, with 73 million adults currently affected, projected to rise to 136 million by 2045. In certain populations within countries like Saudi Arabia and Egypt, diabetes prevalence exceeds 20%. Additionally, hypertension is a significant factor contributing to CKD, with over 30% of adults in the region having high blood pressure, which increases the risk of CKD and ESRD.Moreover, increased awareness and early screening initiatives are crucial catalysts for market growth. Public health campaigns aimed at educating people about the importance of early detection and management of kidney diseases play a vital role in preventing the progression of these conditions to ESRD. Cultural factors greatly influence healthcare-seeking behavior, and initiatives are being implemented to improve health services for diverse populations. There is also a growing preference for home-based dialysis solutions, particularly in light of concerns regarding hospital-acquired infections and the demand for more flexible treatment options.Despite challenges such as regional disparities in healthcare access and the need for infrastructure improvements, the Middle East and Africa region holds significant growth potential. This potential is especially evident as healthcare systems evolve and international investments in healthcare continue to rise.

Market Segmentation

AnalysisThe dialysis equipment market is segmented based on product, application, and end user.
By Product: The market includes hemodialysis equipment, peritoneal dialysis equipment, concentrates and solutions, catheters and tubings, and other products, with hemodialysis equipment dominating the market in 2024.
By Application: The main segments are hemodialysis and peritoneal dialysis, with hemodialysis holding the largest share in 2024.
By End User: The market is divided into in-center dialysis settings and home care settings, with in-center dialysis settings holding the largest share in 2024.

Market Outlook

The Middle East and Africa dialysis equipment market is divided into several countries, including Turkiye, UAE, Saudi Arabia, Bahrain, Oman, Egypt, South Africa, Algeria, Nigeria, Kuwait, and Qatar. The market is experiencing substantial growth driven by the rising burden of chronic kidney disease (CKD) and end-stage renal disease (ESRD). For example, the average prevalence of ESRD in Gulf Cooperation Council (GCC) countries is 551 per million population.Healthcare spending in the GCC is estimated to be between 2% and 5.5% of GDP, with significant increases anticipated, including a projected 12% rise in medical healthcare spending in the Middle East by 2025. Unique challenges faced by the region, such as a limited skilled workforce and varying reimbursement policies, may hinder rapid growth. However, significant investments in healthcare infrastructure, particularly in some African nations, and the increasing patient volume are expected to support steady market expansion.

Country Insights

The dialysis equipment market in the Middle East and Africa is segmented by region into Turkiye, the UAE, Saudi Arabia, Bahrain, Oman, Egypt, South Africa, Algeria, Nigeria, Kuwait, and Qatar. In 2024, Turkiye held the largest market share. In Turkiye, the dialysis equipment industry is significantly influenced by demographic factors, particularly the increasing prevalence of chronic diseases. Notably, individuals aged 65 and older accounted for 106% of the population, a figure projected to rise from 9.1% in 2019, according to statistics released by TURKSTAT in March 2025. This statistic is crucial, as it highlights the population at higher risk for kidney disease. Chronic kidney disease (CKD) is a serious public health issue in Turkiye, with an expected overall prevalence of 12.3% in the general population by 2027, including many undiagnosed cases. There is a clear correlation between the rise in chronic diseases in Turkiye and the high incidence of conditions like diabetes and hypertension, which can result in kidney damage. According to the WHO (2023) country profile, diabetes prevalence among the Turkish population was projected to be 15.8% in 2023, with expectations of rising to 19.1% by 2045. Hypertension rates also remain high, particularly concerning cardiovascular health and end-stage renal disease (ESRD). As reported by the Turkish Society of Nephrology (2023) in April 2025, there were 89,527 patients receiving kidney replacement therapy by the end of 2023, translating to a prevalence rate of 1,048.7 patients per million population. Hemodialysis is the primary treatment modality, utilized by 70.88% of prevalent patients in 2023, with diabetes identified as the leading cause of ESRD among new patients, accounting for 33.9% of cases. The continuous growth in the number of dialysis patients highlights the persistent demand for dialysis equipment and related consumables in Turkiye.In South Africa, the dialysis equipment market is shaped by the increasing burden of CKD, driven by prevalent non-communicable diseases against the backdrop of an aging population and disparities in the healthcare sector. While South Africa has a relatively youthful demographic compared to some developed nations, the percentage of individuals aged 60 and above is steadily increasing, reaching approximately 9.7% (6.13 million) in 2024, according to Statistics South Africa. This demographic shift results in a larger population vulnerable to kidney diseases. CKD poses a significant health challenge, with prevalence estimates varying but consistently linked to high rates of diabetes and hypertension. Diabetes affects 11.3% of South African adults, as reported by IDF data, and recent studies highlight its role in accelerating CKD progression.

Key Players

Key players in the Middle East and Africa dialysis equipment market include Fresenius Medical Care AG & Co KGaA, Baxter International Inc., B. Braun SE, Nipro Corp, Medtronic Plc, Nikkiso Co Ltd, Teleflex Inc, Asahi Kasei Medical Co., Ltd., Terumo Corp, and DaVita Inc. These companies employ various strategies such as expansion, product innovation, and mergers and acquisitions to maintain competitiveness and offer innovative products to their consumers. Show more